31.Musser，JM，Kapur V，Williams DL，Kreiswirth BN，van Soolingen D，van Embden JD.Characterization of the catalase-peroxidase gene （katG）and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing：restricted array of mutations associated with drug resistance.J Infect Dis，1996，173：196-202.
32.Ramaswamy SV，Reich R，Dou SJ，Jasperse L，Pan X，et al.Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother，2003，47：1241-1250.
33.Wilson，TM，Collins DM.ahpC，a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex.Mol.Microbiol，1996，19：1025-1034.
34.Sherman DR，Mdluli K，Hickey MJ，Arain TM，Morris S L，Barry CE III，Stover CK.Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.Science 1996，272：1641-1643
35.Ferrari G，Langen H，Naito M，Pieters J.A coat protein on phagosomes involved in the intracellular survival of mycobacteria.Cell，199914，97（4）：435-47.
36.Wilson T，de Lisle GW，Marcinkeviciene JA，Blanchard JS，Collins DM.Antisense RNA to ahpC，an oxidative stress defence gene involved in isoniazid resistance，indicates that AhpC of Mycobacterium bovis has virulence properties.Microbiology，1998，144：2687–2695.
37.Heym B，Stavropoulos E，Honore N，Domenech P，Saint-Joanis B，et al.Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis.Infect Immun.1997，65：1395–1401.
38.Kelley CL，Rouse DA，Morris SL.Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.Antimicrob Agents Chemother，1997，41（9）：2057-2058.
39.Wilson，M，DeRisi J，Kristensen H-H，Imboden P，Rane S，Brown PO，Schoolnik GK.Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.Proc.Natl.Acad.Sci.USA，1999，96：12833-12838.
40.Miesel L，Weisbrod T，Marcinkeviciene JA，Bittman R，Doshi P，Sacchettini JC，Jacobs WR Jr.NADH dehydrogenase defects confer resistance to isoniazid and conditional lethality in Mycobacterium smegmatis.J Bacteriol，1998，180：2459-2467.
41.Chen P，Bishai W R.Novel selection for isoniazid resistance genes supports a role for NAD+-binding proteins in mycobacterial INH resistance.Infect Immun，1998，66：5099-5106.
42.Ruusala T，Kurland GC.Streptomycin preferentially perturbs ribosomal proofreading.Mol Gen Genet，1984，198：100.
43.彭义利，王国斌，张舒林，等.结核分枝杆菌链霉素耐药分离株rpsL基因突变的检测.中华检验医学杂志，2000，23：148-149.
44.Morris S，Bai GH，Suffys P，et al.Molecular mechanisms of multiple drug resistance in clinical isolates of M.tuberculosis.JID，1995，171：954.
45.Finken M，Kirschner P，Meier A，et al.Molecular basis of streptomycin resistancein M.tuberculosis：alterations of the ribosomal protein S12gene and point mutations with in a functional 16S ribosomal RNA pseudoknot.Mol Microbiol，1993，9：1239.
46.Post FA，Willcox PA，Mathema B，Steyn LM，et al.Genetic Polymorphism in Mycobacterium tuberculosis Isolates from Patients with Chronic Multidrug-Resistant Tuberculosis.JID，2004，Vol.190，99-106
47.Wu XQ，Zhang JX，Zhuang YH，et al.Molecular mechanism of drug resistance in Mycobacterium tuberculosis clinical isolates.Chinese Medical Journal，1999，112：524-528
48.Ramaswamy SV，Amin AG，Goksel S，et al.Molecular genetic analysis of nucleotide polymorphisms associated with Ethambutol resistance in human isolates of Mycobacterium tuberculosis.2000，44：326.
49.Telenti A，Philipp W J，Sreevatsan S，et al.The EMB operon，a gene cluster of Mycobacterium tuberculosis involved in resistance to Ethambutol.Nature Medicine，1997，3：567
50.Belanger AE，Besra GS，Ford ME，MikusováK，Belisle JT，Brennan PJ，Inamine JM.The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug Ethambutol.Proc Natl Acad Sci USA，1996，93：11919–11924
51.Sreevatsan S，Stockbauer K E，Pan X，et al.Ethambutol resistance in Mcobacterium tuberculosis：critical role of embB mutations.Antimicrob Agents Chemother，1997；41（8）：1677
52.张舒林，孙战强，伍学强，等.结核杆菌对乙胺丁醇耐药突变基因检测方法的建立.中华检验医学杂志，2004，27：169-170
53.Ramaswamy SV，Dou SJ，Rendon A，Yang Z，Cave MD，Graviss EA.Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey，Mexico.J Med Microbiol，2004，53：107-113.
54.Alcaide F，Pfyffer GE，Telenti A.Role of embB in natural and acquired resistance to Ethambutol in mycobacteria.Antimicrob Agents Chemother，1997，41：2270–2273.
55.Lety MA，Nair S，Berche P，Escuyer V.A single point mutation in the embB gene is responsible for resistance to Ethambutol in Mycobacterium snegmatis.Antimicrob Agents Chemother 1997，41：2629–2633
56.Tracevska T，Jansone I，Nodieva A，Marga O，Skenders G，Baumanis V.Characterisation of rpsL，rrs and embB mutations associated with streptomycin and Ethambutol resistance in Mycobacterium tuberculosis.Res Microbiol，2004，155（10）：830-834.
57.Mokrousov I，Otten T，Vyshnevskiy B，Narvskaya O.Detection of embB306mutations in Ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia：implications for genotypic resistance testing.J Clin Microbiol，2002，40：3810-3813.
58.van Rie A，Warren R，Mshanga I，Jordaan AM，van der Spuy GD，Richardson M，Simpson J，Gie RP，Enarson DA，Beyers N，van Helden PD，Victor TC.Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.J Clin Microbiol，2001，39：636-641
